Silphium Asset Management LTD Johnson & Johnson Transaction History

Silphium Asset Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jan 30, 2025	SELL	$168.19 - $186.01 $445,535 - $492,740	-2,649 Closed	0 $0
Q1 2022 Jan 30, 2025	BUY	$158.14 - $179.59 $205,581 - $233,467	1,300 Added 96.37%	2,649 $469 Million
Q4 2021 Jan 30, 2025	SELL	$155.93 - $173.01 $162,634 - $180,449	-1,043 Reduced 43.6%	1,349 $231 Million
Q3 2021 Jan 30, 2025	BUY	$161.5 - $179.47 $386,308 - $429,292	2,392 New	2,392 $386 Million
Q1 2019 Jan 30, 2025	BUY	$125.72 - $139.79 $290,036 - $322,495	2,307 New	2,307 $322 Million
Q4 2018 Jan 30, 2025	SELL	$122.84 - $147.84 $418,393 - $503,543	-3,406 Closed	0 $0
Q1 2018 Jan 30, 2025	SELL	$125.1 - $148.14 $366,042 - $433,457	-2,926 Reduced 46.21%	3,406 $436 Million
Q4 2017 Jan 30, 2025	BUY	$131.22 - $143.62 $830,885 - $909,401	6,332	6,332 $885 Million

4,309

1.68B

17.7M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Silphium Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Silphium Asset Management LTD with notifications on news.